Skip to content
naulon

No retraction, correction or concern found when last checked on Nov 2, 2026.

Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox

Jakob Wirbel, Konrad Zych, Morgan Essex and 6 more

Genome Biology · 2021 · CC BY

doi:10.1101/2020.02.06.931808

Abstract

Supplementary Information. The online version contains supplementary material available at 10.1186/s13059-021-02306-1.

References 113

  1. 1.

    Schmidt TSB, Raes J, Bork P. The human gut microbiome: from association to modulation. Cell. 2018;172:1198-1215.

    Not in our library10.1016/j.cell.2018.02.044

  2. 2.

    Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. Mass Medical Soc; 2016;375:2369–2379.

    Not in our library10.1056/nejmra1600266

  3. 3.

    Garrett WS. The gut microbiota and colon cancer. Science. 2019;364:1133-1135.

    Not in our library10.1126/science.aaw2367

  4. 4.

    Gevers D, Kugathasan S, Denson LA. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15:382–92 Elsevier.

    Not in our library10.1016/j.chom.2014.02.005

  5. 5.

    Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4:293-305.

    Not in our library10.1038/s41564-018-0306-4

  6. 6.

    Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21:895-905.

    Not in our library10.1038/nm.3914

  7. 7.
  8. 8.
  9. 9.

    Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut. 2016;65:2035-2044.

    Not in our library10.1136/gutjnl-2016-312729

  10. 10.

    Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies. Science. 2018;359:1366-1370.

    Not in our library10.1126/science.aar6918

  11. 11.

    Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528:262-266.

    Not in our library10.1038/nature15766

  12. 12.
  13. 13.
  14. 14.
  15. 15.

    Paulson JN, Stine OC, Bravo HC, Pop M. Differential abundance analysis for microbial marker-gene surveys. Nat Methods. 2013;10:1200-1202.

    Not in our library10.1038/nmeth.2658

  16. 16.

    Mandal S, Van Treuren W, White RA, Eggesbø M, Knight R, Peddada SD. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb Ecol Health Dis. 2015;26:27663.

    Not in our library10.3402/mehd.v26.27663

  17. 17.

    Knights D, Parfrey LW, Zaneveld J, Lozupone C, Knight R. Human-associated microbial signatures: examining their predictive value. Cell Host Microbe. 2011;10:292-296.

    Not in our library10.1016/j.chom.2011.09.003

  18. 18.

    Knights D, Costello EK, Knight R. Supervised classification of human microbiota. FEMS Microbiol Rev. 2011;35:343-359.

    Not in our library10.1111/j.1574-6976.2010.00251.x

  19. 19.
  20. 20.
  21. 21.
  22. 22.

    Bang S, Yoo D, Kim S-J, Jhang S, Cho S, Kim H. Establishment and evaluation of prediction model for multiple disease classification based on gut microbial data. Sci Rep. 2019;9:10189.

    Not in our library10.1038/s41598-019-46249-x

  23. 23.
  24. 24.

    Le Goallec A, Tierney BT, Luber JM, Cofer EM, Kostic AD, Patel CJ. A systematic machine learning and data type comparison yields metagenomic predictors of infant age, sex, breastfeeding, antibiotic usage, country of origin, and delivery type. PLoS Comput Biol. 2020;16:e1007895.

    Not in our library10.1371/journal.pcbi.1007895

  25. 25.
  26. 26.

    Alkanani AK, Hara N, Gottlieb PA, Ir D, Robertson CE, Wagner BD, et al. Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes. 2015;64:3510-3520.

    Not in our library10.2337/db14-1847

  27. 27.

    Nielsen HB, Almeida M, Juncker AS, Rasmussen S, Li J, Sunagawa S, et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat Biotechnol. 2014;32:822-828.

    Not in our library10.1038/nbt.2939

  28. 28.

    Lewis JD, Chen EZ, Baldassano RN, Otley AR, Griffiths AM, Lee D, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’s disease. Cell Host Microbe. 2015;18:489-500.

    Not in our library10.1016/j.chom.2015.09.008

  29. 29.

    He Q, Gao Y, Jie Z, Yu X, Laursen JM, Xiao L, et al. Two distinct metacommunities characterize the gut microbiota in Crohn’s disease patients. Gigascience. 2017;6:1-11.

    Not in our library10.1093/gigascience/gix050

  30. 30.
  31. 31.

    Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139:1844-54.e1.

    Not in our library10.1053/j.gastro.2010.08.049

  32. 32.
  33. 33.
  34. 34.

    Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, et al. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nat Commun. 2015;6:6528.

    Not in our library10.1038/ncomms7528

  35. 35.

    Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. 2017;66:70-78.

    Not in our library10.1136/gutjnl-2015-309800

  36. 36.
  37. 37.

    Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25:679-689.

    Not in our library10.1038/s41591-019-0406-6

  38. 38.

    Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 2019;25:667-678.

    Not in our library10.1038/s41591-019-0405-7

  39. 39.

    Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019;25:968-976.

    Not in our library10.1038/s41591-019-0458-7

  40. 40.

    Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6:320-329.

    Not in our library10.1038/ismej.2011.109

All 113 references

Cited by papers we hold 10

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.